Top compounds associated with response to CYP2F1


Feature Type Standardized
Nominal ANOVA
mRNA Parthenolide GDSC1000 pan-cancer AAC 0.11 0.03
mRNA phloretin CTRPv2 pan-cancer AAC 0.072 0.03
mRNA TW 37 GDSC1000 pan-cancer AAC -0.069 0.03
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.04
mRNA AG-014699 GDSC1000 pan-cancer AAC -0.07 0.04
mRNA MLN4924 GDSC1000 pan-cancer AAC -0.082 0.04
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.076 0.04
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.072 0.04
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.04
mRNA Doxorubicin gCSI pan-cancer AAC -0.1 0.05
Download CSV